Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Leukemia. 2020 Jul 12;34(12):3404–3407. doi: 10.1038/s41375-020-0974-y

Table 1.

Multivariable Analysis of Risk Factors for Grade 3 or Higher Transaminase Elevation

Variable HR (95% CI) p-Value
Prior therapy
Yes 0.47 (0.35, 0.63) <0.001
Age, y+
<55 2.64 (1.50, 4.63) 0.003
≥55 to <65 1.77 (1.07, 2.91)
≥65 to <75 1.36 (0.84, 2.21)
*

Factors considered: IGHV mutation, del(17p), age, combination with BR, prior therapy, and their interactions

+

Compared with ≥75 y.

CI, confidence interval; HR, hazard ratio